Maged Shenouda - 16 Dec 2022 Form 4 Insider Report for RELMADA THERAPEUTICS, INC. (RLMD)

Role
Chief Financial Officer
Signature
/s/ Maged Shenouda
Issuer symbol
RLMD
Transactions as of
16 Dec 2022
Net transactions value
$0
Form type
4
Filing time
20 Dec 2022, 16:34:03 UTC
Previous filing
26 May 2022
Next filing
30 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RLMD Stock Option (right to buy) Award $0 +194,917 $0.000000 194,917 16 Dec 2022 Common Stock 194,917 $3.37 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 62,560 of the shares are immediately vested; 132,357 shares vest in 16 equal quarterly installments commencing on March 16, 2023.